Evaluation of the Activity of a Pharmacological “Anticellulitis” Product vs. a Reference Product on the Market
Condition(s):HealthyLast Updated:July 21, 2014Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:July 21, 2014Completed
Condition(s):Atopic Dermatitis; Secondary InfectionLast Updated:September 22, 2016Completed
Condition(s):Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin InfectionsLast Updated:July 26, 2012Completed
Condition(s):Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin InfectionsLast Updated:July 26, 2012Completed
Condition(s):Skin Diseases, Infectious; Staphylococcal Skin InfectionsLast Updated:November 1, 2016Completed
Condition(s):LymphedemaLast Updated:September 17, 2020Completed
Condition(s):Community-Acquired Staphylococcus AureusLast Updated:November 6, 2016Completed
Condition(s):Neonatal Abstinence SyndromeLast Updated:July 17, 2019Completed
Condition(s):Community-Acquired Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections; Meningitis; GastroenteritisLast Updated:September 14, 2012Completed
Condition(s):Infection, Soft Tissue; Infection, Wound; Cellulitis; Diabetic Foot UlcerLast Updated:October 23, 2018No longer available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.